| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5a76693b3e0d40af1ffd8a82b5a480a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46c81f5435d05bc68d5f6059cea6f738
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca785813b4e9befd4499747ec61f738d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0c9c24f9afebd23e58ea7b751d79a35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a28a4f50637e7a498380d7e43e6ee87e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8a7c27a26098d27b5c43829d5c77e99 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2007-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c466d8025af4c65d9531cfaf6a9e3582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95b07f5ab860b57d8d54fdff24ca8fd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87f37cac7a2a89048742a4d1a8e27791
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b24e908f19e70f4a66a402bb6055b8b3 |
| publicationDate |
2007-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007132156-A2 |
| titleOfInvention |
Materials and methods relating to cancer diagnosis, prognosis and treatment based on the determination of novel molecular markers in tumors |
| abstract |
The invention provides materials and methods for classifying tumours, for diagnosing and treating cancers and for determining a prognosis and/or treatment regimen for an individual with cancer. Serine/threonine kinases which show altered gene status and/or expression levels in tumour cells compared to normal cells are identified herein and these serine/threonine kinases provide specific tumour markers and tools for cancer diagnosis, prognosis and therapeutic applications. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10302644-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015500001-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114921546-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114921546-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010043713-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010043713-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016073184-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108220431-A |
| priorityDate |
2006-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |